CD40 antibody

Catalog No. ABIN2618548

This anti-CD40 antibody is a Rat Monoclonal antibody detecting CD40 in FACS and Func. Suitable for Mouse.

Quick Overview for CD40 antibody (ABIN2618548)

Target: CD40

Reactivity: Mouse

Host: Rat

Clonality: Monoclonal

Conjugate: This CD40 antibody is un-conjugated

Application: Flow Cytometry (FACS), Functional Studies (Func)

Clone: FGK45

Product Details anti-CD40 Antibody

Specificity: Recognizes mouse CD40.

Purification: Protein G purified from tissue culture supernatant

Immunogen: Recombinant mouse CD40 fusion protein.

Type of Immunogen: Fusion protein

Isotype: IgG2a

Application Details

Application Notes: Approved: Flo, Func

Usage: Functional Application - Activates B and NK cells in vivo and in vitro. For in vivo studies use the preservative free antibody (Prod. No. < a title="anti-CD40 (mouse), mAb (FGK45) (preservative free)" href="http://www.adipogen.com/ag-20b-0036pf/anti-cd40-mouse-mab-fgk45-preservative-free.html" target="_self">AG-20B-0036PF.

Comment:

Target Species of Antibody: Mouse

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS, 0.02 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid freeze-thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.

Target Details for CD40

Target: CD40

Alternative Name: CD40

Background: Name/Gene ID: CD40
Family: TNF Receptor

Synonyms: CD40, B-cell surface antigen CD40, B cell-associated molecule, B cell surface antigen CD40, CD40 antigen, CD40 type II isoform, p50, Bp50, CD40L receptor, CDW40, TNFRSF5

Gene ID: 958

Pathways: NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints